相关实验视频
Updated: Jan 18, 2026
06:17
Expression and Purification of Virus-like Particles for Vaccination
Published on: June 2, 2016
22.7K
开发一种交叉保护的普通感冒冠状病毒疫苗
Tanushree Dangi1, Shiyi Li1, Pablo Penaloza-MacMaster1,2
1Department of Microbiology-Immunology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
bioRxiv : the preprint server for biology
|June 4, 2025
概括
一种针对普通感冒冠状病毒OC43的新型mRNA疫苗显示出有希望. 它不仅对OC43进行保护,而且对小鼠的HKU1和MHV-A59等相关病毒提供交叉保护.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 疫苗开发 疫苗开发
背景情况:
- 常见感冒冠状病毒 (例如,OC43,HKU1) 在健康个体中引起轻度疾病,但在高风险群体中引起严重疾病.
- 目前对于普通感冒冠状病毒没有经过临床批准的疫苗.
- 开发有效的针对这些流行病毒的疫苗是一个重要的公共卫生需求.
研究的目的:
- 开发和评估针对OC43冠状病毒尖端蛋白的mRNA疫苗候选人.
- 在小鼠模型中评估疫苗在保护OC43感染方面的有效性.
- 调查疫苗对其他相关冠状病毒的交叉保护潜力.
主要方法:
- 一种mRNA疫苗被设计为表达来自OC43冠状病毒的稳定尖端蛋白.
- 在C57BL/6小鼠挑战模型中测试了疫苗的免疫性和保护效果.
- 免疫反应,包括抗体和T细胞反应,在接种疫苗后和挑战后进行了分析.
主要成果:
- 这种OC43 mRNA疫苗成功诱导了OC43特异性免疫反应.
- 该疫苗表现出对其他胚胎病毒的交叉反应免疫力,包括HKU1和小鼠肝炎病毒 (MHV-A59).
- 接种疫苗的小鼠受到致命的OC43挑战的保护,也显示出对MHV-A59挑战的保护,由非中和抗体介导.
结论:
- 基于OC43尖端蛋白的mRNA疫苗是预防普通感冒冠状病毒的可行策略.
- 该疫苗引起交叉保护性免疫力,这表明单一疫苗有可能向多个胚胎病毒.
- 非中和抗体在观察到的交叉保护中起着关键作用,为未来的疫苗设计提供了洞察力.
相关概念视频
00:42Cross-reactivity
32.9K
Overview
32.9K
01:22Development of Immunocompetence
795
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
795
01:51Vaccinations
51.3K
Overview
51.3K
01:29Immune Response Against Viral Pathogens
1.8K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.8K